Abbott Laboratories (ABT) earnings
ABT earnings moved a median of -0.24% by the close. Quarterly and annual ABT reports and results, each read against the price at its own news timestamp. Back to the ABT overview →
33 measured ABT earnings events.
Where these ABT earnings landedvs 33 measured ABT earnings reactions
| Middle 50% of ABT earnings reactions | -0.91% to +0.96% |
|---|---|
| Median reaction (to close) | -0.24% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 ABT earnings events with a measured close landed between -0.91% and +0.96%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Abbott hosts conference call for third-quarter earnings | Press release | -0.72% | -1.73% | |
| Form 10-Q ABBOTT LABORATORIES For: Jun 30 | SEC filing · Form 10-Q | +0.48% | +0.96% | |
| Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance | Press release | +3.71% | +3.63% | |
| Abbott hosts conference call for second-quarter earnings | Press release | +1.47% | +2.27% | |
| Form 10-Q ABBOTT LABORATORIES For: Mar 31 | SEC filing · Form 10-Q | -0.19% | -0.52% | |
| Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences | Press release | +0.34% | -1.58% | |
| Abbott hosts conference call for first-quarter earnings | Press release | +0.12% | -0.03% | |
| Form 10-K ABBOTT LABORATORIES For: Dec 31 | SEC filing · Form 10-K | +0.59% | +2.81% | |
| Abbott hosts conference call for fourth-quarter earnings | Press release | +0.77% | +0.80% | |
| Form 10-Q ABBOTT LABORATORIES For: Sep 30 | SEC filing · Form 10-Q | +0.39% | -0.38% | |
| Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance | Press release | +0.25% | +1.13% | |
| Abbott Hosts Conference Call for Third-Quarter Earnings | Press release | +0.31% | -1.05% | |
| Form 10-Q ABBOTT LABORATORIES For: Jun 30 | SEC filing · Form 10-Q | +0.30% | -1.10% | |
| Abbott Reports Second-Quarter 2025 Results | Press release | -2.29% | -5.01% | |
| Abbott Hosts Conference Call for Second-Quarter Earnings | Press release | +0.07% | -2.55% | |
| Form 10-Q ABBOTT LABORATORIES For: Mar 31 | SEC filing · Form 10-Q | -0.05% | +1.21% | |
| Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance | Press release | +0.92% | -0.91% | |
| Abbott Hosts Conference Call for First-Quarter Earnings | Press release | -0.29% | +0.69% | |
| Form 10-K ABBOTT LABORATORIES For: Dec 31 | SEC filing · Form 10-K | +0.08% | +0.16% | |
| Abbott Hosts Conference Call for Fourth-Quarter Earnings | Press release | +0.18% | -0.24% | |
| Form 10-Q ABBOTT LABORATORIES For: Sep 30 | SEC filing · Form 10-Q | -1.23% | -0.42% | |
| Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range | Press release | -1.30% | -0.56% | |
| Abbott Hosts Conference Call for Third-Quarter Earnings | Press release | -1.01% | -1.31% | |
| Form 10-Q ABBOTT LABORATORIES For: Jun 30 | SEC filing · Form 10-Q | -0.09% | +3.26% | |
| Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance | Press release | -0.19% | -0.49% | |
| Abbott Hosts Conference Call for Second-Quarter Earnings | Press release | -0.35% | -0.50% | |
| Form 10-Q ABBOTT LABORATORIES For: Mar 31 | SEC filing · Form 10-Q | +0.35% | -0.16% | |
| Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges | Press release | -2.79% | -1.74% | |
| Abbott Hosts Conference Call for First-Quarter Earnings | Press release | +0.06% | +0.34% | |
| Form 10-K ABBOTT LABORATORIES For: Dec 31 | SEC filing · Form 10-K | +0.00% | +2.10% | |
| Abbott Hosts Conference Call for Fourth-Quarter Earnings | Press release | -0.04% | -0.42% | |
| Form 10-Q ABBOTT LABORATORIES For: Sep 30 | SEC filing · Form 10-Q | +0.03% | +1.03% | |
| Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range | Press release | -2.60% | -0.12% |
Keep exploring
More ABT: analyst actions → · SEC filings → · ABT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Intec Pharma Ltd (NTEC) | 437 | -0.26% | 36% |
| VALERITAS HOLDINGS (VLRX) | 437 | -0.35% | 28% |
| The Cigna Group (CI) | 435 | +0.10% | 58% |
| IMPRIMIS PHARMACEUTICALS (IMMY) | 435 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.